CRMD (CorMedix Inc.) Stock Analysis - Hedge Fund Holdings
CorMedix Inc. (CRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, CRMD trades at $7.94 with a market cap of $620.55M and a P/E ratio of 3.42. CRMD moved +1.41% today. Year to date, CRMD is -34.95%; over the trailing twelve months it is -38.14%. Its 52-week range spans $5.60 to $17.43. Analyst consensus is strong buy with an average price target of $14.25. Rallies surfaces CRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CRMD stock?
Hedge funds tracked by Rallies that own CRMD include Elliott Investment and Sculptor Capital. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CorMedix Inc..
CRMD Key Metrics
Key financial metrics for CRMD
Metric
Value
Price
$7.94
Market Cap
$620.55M
P/E Ratio
3.42
EPS
$2.32
Dividend Yield
0.00%
52-Week High
$17.43
52-Week Low
$5.60
Volume
544
Avg Volume
0
Revenue (TTM)
$400.05M
Net Income
$181.01M
Gross Margin
85.83%
Top Hedge Funds Holding CRMD
Elliott Investment holds 2.44M shares of CRMD, changed -57.42% as of Mar 31, 2025.
Sculptor Capital holds 335.90K shares of CRMD, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own CRMD include Elliott Investment and Sculptor Capital. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for CorMedix Inc..
Does Rallies show 13F holders for CRMD?
Yes. Rallies tracks hedge fund and 13F ownership data for CRMD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CRMD. It does not provide personalized investment advice.
